Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

20 Oct 2020

Abstract excerpt

Body composition refers to the proportional content of body fat mass and lean body mass that can lead to a continuum of different phenotypes ranging from cachectic/sarcopenic state to obesity. The heterogenetic phenotypes of body composition can contribute to formation of some cancer types and can sometimes lead to disparate outcomes. Both of these extremes of the spectrum exist in patients with non-small cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Diagnosis and Treatment
Share to Cancer Immunotherapy and Biomarkers
Share to Nutrition and Health in Aging

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33194687
DOI: 10.3389/fonc.2020.576314

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase InhibitorsPMID 33194687Read ↗

Multimodal Analysis Reveals Differential Immuno-Metabolic Features in Lung Squamous Cell Carcinoma and AdenocarcinomaSemantic proximity Read ↗

Characterization of pretreatment cachexia through cytokine and nutritional analysis in lung cancer: the Marató cohortSemantic proximity Read ↗

The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality.Semantic proximity Read ↗

Host-Derived Immunometabolic Biomarkers Identify Prognostic Profiles under Immunotherapy in Advanced NSCLC: the SARC-LUNG StudySemantic proximity Read ↗

Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients.Semantic proximity Read ↗

Impact of body composition and muscle health phenotypes on survival outcomes in colorectal cancer: a multicenter cohort.Semantic proximity Read ↗

The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma.Semantic proximity Read ↗

Sex-specific Body Composition Features Impacting Survival Outcomes in Surgically Managed Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Body composition phenotypes, and specific adiposity and lean mass indicators, and their lifestyle determinants among adult childhood cancer survivors - The iBoneFIT adult study.Semantic proximity Read ↗

Pathophysiological remodeling of the skeletal muscle microenvironment in patients with lung cancerSemantic proximity Read ↗

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myelomaSemantic proximity Read ↗

Association of computed tomography scan–assessed body composition with immune and PI3K/AKT pathway proteins in distinct breast cancer tumor componentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.